LYNPARZA® (olaparib) Receives Three New Approvals in Japan

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. GWRE
10. CIEN

Go back to LYNPARZA® (olaparib) Receives Three New Approvals in Japan
Merck & Co. (NYSE: MRK) Delayed: 150.33 -2.01 (1.32%)
Previous Close $152.34    52 Week High $65.46 
Open $150.83    52 Week Low $47.97 
Day High $152.22    P/E 102.27 
Day Low $150.09    EPS $1.47 
Volume 4,395,788